Effect of oral administration of losartan, prazosin, and verapamil on peritoneal solute transport in continuous ambulatory peritoneal dialysis patients

Peritoneal Dialysis International

Volumn 25, Issue 6, 2005, Pages 576-582

  Rojas Campos, Enrique ^a   Cortés Sanabria, Laura ^a   Martínez Ramírez, Héctor R ^a   González, Liliana ^a   Martín del Campo, Fabiola ^a   González Ortiz, Manuel ^a   Cueto Manzano, Alfonso M ^a  

^a HOSPITAL DE ESPECIALIDADES   (Mexico)

Author keywords

Antihypertensive drugs; Dialysis adequacy; Peritoneal transport rate

Indexed keywords

CREATININE; DIALYSIS FLUID; GLUCOSE; LOSARTAN; POTASSIUM; PRAZOSIN; PROTEIN; SODIUM; UREA; VERAPAMIL;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; CROSSOVER PROCEDURE; DRUG ACTIVITY; DRUG EFFECT; FEMALE; HUMAN; KIDNEY FAILURE; MALE; MEMBRANE TRANSPORT; OPEN STUDY; PERITONITIS; PRIORITY JOURNAL; PROTEIN TRANSPORT; SOLUTE; STATISTICAL ANALYSIS; ULTRAFILTRATION;

EID: 30944436265     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080502500614     Document Type: Article

References (35)

1. Wu G, Wieczorowska-Tobis K, Polubinska A, Korybalska K, Filas V, Tam P, et al. N-acetylglucosamine changes permeability of peritoneum during chronic peritoneal dialysis in rats. Perit Dial Int 1998; 18:217-24.
2. Breborowicz A, Tobis KW, Korybalska K, Polubinska A, Radkowski M, Oreopoulos DG. The effect of a nitric oxide inhibitor (L-NAME) on peritoneal transport during dialysis in rats. Perit Dial Int 1998; 18:188-92.
3. Kumano K, Go M, Ning H, Sakai T. Effects of vasodilators on peritoneal solute and fluid transport in rat peritoneal dialysis. Adv Perit Dial 1996; 12:27-32.
4. Thitiarchakul S, Lal SM, Moore HL, Nolph KD. Effects of chlorpromazine or diltiazem given intraperitoneally alone or in combination on peritoneal transport of solute and water. Adv Perit Dial 1999; 15:7-11.
5. Douma CE, Hiralall JK, de Waart DR, Struijk DG, Krediet RT. Icodextrin with nitroprusside increases ultrafiltration and peritoneal transport during long CAPD dwells. Kidney Int 1998; 53:1014-21.
6. Wang T, Cheng H, Heimbürger O, Bergström J, Lindholm B. Vasodilatation by intraperitoneal addition of nitroprusside is not a model for high peritoneal transport. Adv Perit Dial 1999; 15:53-9.
7. Vargemezis B, Pasadakis P, Thodis E. The effect of calcium antagonist on the peritoneal membrane in patients on CAPD. Adv Perit Dial 1989; 5:8-11.
8. Ripley EBD, Gehr TWB, Kish CW, Sica DA. Hormonal, blood pressure, and peritoneal transport response to short-term ACE inhibition. Perit Dial Int 1994; 14:378-83.
9. El-Sherif AK, Rizkalla NH, Essawy MH, El-Gohary AM. Minoxidil selectively improves peritoneal ultrafiltration. Perit Dial Int 1996; 16(Suppl 1):S91-4.
10. Favazza A, Montanaro D, Messa P, Antonucci F, Gropuzzo M, Mioni G. Peritoneal clearances in hypertensive CAPD patients after oral administration of clonidine, enalapril, and nifedipine. Perit Dial Int 1992; 12:287-91.
11. Spaia S, Magoula I, Tsapas G, Vayonas G. Effect of pyrazinamide and probenecid on peritoneal urate transport kinetics during continuous ambulatory peritoneal dialysis. Perit Dial Int 2000; 20:47-52.
12. Oreopoulos DG. The optimization of continuous ambulatory peritoneal dialysis. Kidney Int 1999; 55:1131-49.
13. Tzamaloukas AH, Murata GE, Piraino B, Rao P, Bernardini J, Malhotra D, et al. Peritoneal urea and creatinine clearances in continuous peritoneal dialysis patients with different types of peritoneal solute transport. Kidney Int 1998; 53:1405-11.
14. Twardowski ZJ, Nolph KD, Khanna R, Prowant BF, Ryan LP, Moore HL, et al. Peritoneal equilibration test. Perit Dial Bull 1987; 7:138-47.
15. Cueto-Manzano AM, Díaz-Alvarenga A, Correa-Rotter R. Analysis of the peritoneal equilibration test in Mexico and of factors influencing the peritoneal transport rate. Perit Dial Int 1999; 19:45-50.
16. Bajo MA, Selgas R. Adecuación en diálisis peritoneal. In: Montenegro J, Olivares J, eds. La Diálisis Peritoneal. Madrid: DIBE SL; 1999: 273-90.
17. Canaud B, Bosc JY, Cabrol L, Leray-Moragues H, Navino C, Verzetti G, et al. Urea as a marker of adequacy in hemodialysis: lesson from in vivo urea dynamics monitoring. Kidney Int Suppl 2000; 76:S28-40.
18. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-52.
19. Park MS, Lee EY, Lee NS, Waniewski J, Lindholm B, Lee HB. The effects of ouabain and potassium on peritoneal fluid and solute transport characteristics. Perit Dial Int 1998; 18:402-9.
20. Vargemezis V, Pasadakis P, Thodis E. Effect of a calcium antagonist (verapamil) on the permeability of the peritoneal membrane in patients on continuous ambulatory peritoneal dialysis. Blood Purif 1989; 7:309-13.
21. Maher IF, Hirszel IP, Lasrich M. An experimental model for study of pharmacological and hormonal influences on peritoneal dialysis. Contrib Nephrol 1979; 17:131-8.
22. Neglia D, Sambuceti G, Giorgetti A, Bartoli M, Salvadori P, Sorace O, et al. Effects of long-term treatment with verapamil on left ventricular function and myocardial blood flow in patients with dilated cardiomyopathy without overt heart failure. J Cardiovasc Pharmacol 2000; 36: 744-50.
23. Tschaikowsky K, Ritter J, Schröppel K, Kühn M. Volatile anesthetics differentially affect immunostimulated expression of inducible nitric oxide synthase: role of intra-cellular calcium. Anesthesiology 2000; 92:1093-102.
24. Joshi S, Meyers PM, Pile-Spellman J, Wang M, Sahlein DH. Intracarotid verapamil decreases both proximal and distal human cerebrovascular resistance. Anesthesiology 2004; 100:774-81.
25. Breborowicz A, Knapowski J. Local anaesthetic bupivacaine increases the transperitoneal transport of solutes. Part II. In vitro study. Perit Dial Bull 1984; 4:224-8.
26. 2+ effects on peritoneal immune defense mechanisms and ultrafiltration capacity in continuous ambulatory peritoneal dialysis. Perit Dial Int 1993; 13(Suppl 2):S74-8.
27. Nolph K, Gokal R, Mujais S. ISPD Ad hoc committee on ultrafiltration management in peritoneal dialysis. Perit Dial Int 2000; 20(Suppl 4):S3-4.
28. Blake P, Burkart J, Churchill DN, Daugirdas J, Depner T, Hamburger RJ, et al. Recommended clinical practices for maximizing peritoneal dialysis clearances. Perit Dial Int 1996; 16:448-56.
29. Burkart JM, Schreiber M, Korbet SM, Churchill DN, Hamburger RJ, Moran J, et al. Solute clearance approach to adequacy of peritoneal dialysis. Perit Dial Int 1996; 16:457-70.
30. Pannekeet M, Ataserver B, Struijk DG, Krediet R. Analysis of ultrafiltration failure in peritoneal dialysis patients by means of standard peritoneal permeability analysis. Perit Dial Int 1997; 17:144-50.
31. Kawaguchi Y, Hasegawa T, Nakayama M, Kubo H, Shigematu T. Issues affecting the longevity of the continuous peritoneal dialysis therapy. Kidney Int Suppl 1997; 62:S105-7.
32. Cueto-Manzano AM, Gamba G, Correa-Rotter R. Peritoneal protein loss in patients with high peritoneal permeability. Comparison between continuous ambulatory peritoneal dialysis and day-time intermittent dialysis. Arch Med Res 2001; 32:197-201.
33. Oates JA. Antihypertensives and pharmacotherapy in hypertension. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Goodman GA, eds. Las Bases Farmacológicas de la Terapéutica. México DF: McGraw-Hill International; 1997:835-66.
34. Agvald P, Adding LC, Gustafsson LE, Persson MG. Nitric oxide generation, tachyphylaxis and cross-tachyphylaxis from nitrovasodilators in vivo. Eur J Pharmacol 1999; 385:137-45.
35. Miao FJ, Lee TJ. Regional variation in acute vascular homologous tachyphylaxis. J Pharmacol Exp Ther 1992; 260: 644-51.